Browsing: 2026 – April

Longevity and Mortality Investor’s Editor’s Letter for the April 2026 issue.

Two recent litigation cases produced opposite results for the life settlement market.

Industry continues to model the potential upside of a successful rollout of MCED technology despite its newness.

Highest ever volume of buy-in transactions show market in maturation stage.

How durational mortality curves, stochastic A/E analysis and independent audits can strengthen investor confidence and fund sustainability.

Why a different approach might be needed to bring the UK’s secondary life insurance market back to life.